You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lou Gehrig's Disease

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Radiologically Isolated Syndrome, Multiple Sclerosis Trial in United States (Ocrelizumab, Placebo)

Recruiting
  • Radiologically Isolated Syndrome
  • Multiple Sclerosis
  • Los Angeles, California
  • +15 more
Jan 30, 2023

Amyotrophic Lateral Sclerosis, ALS Trial in Seoul (HYNR-CS inj, Control group)

Completed
Has Results
  • Amyotrophic Lateral Sclerosis
  • ALS
  • HYNR-CS inj
  • Control group
  • Seoul, Korea, Republic of
    Hanyang University Hospital
Mar 15, 2022

Amyotrophic Lateral Sclerosis Trial in Worldwide (Masitinib (6.0), Riluzole, Placebo)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Masitinib (6.0)
  • +3 more
  • Birmingham, Alabama
  • +43 more
Mar 4, 2022

Amyotrophic Lateral Sclerosis Trial in United States (Zilucoplan, Verdiperstat, CNM-Au8)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Phoenix, Arizona
  • +67 more
Dec 6, 2022

Amyotrophic Lateral Sclerosis Trial in United States (ALZT-OP1a (cromolyn))

Terminated
  • Amyotrophic Lateral Sclerosis
  • ALZT-OP1a (cromolyn)
  • La Jolla, California
  • +5 more
Nov 1, 2021

Parkinson Disease, Mild Cognitive Impairment, Memory Impairment Trial in Brisbane (Levetiracetam, Placebo)

Recruiting
  • Parkinson Disease
  • +2 more
  • Brisbane, Queensland, Australia
    University of Queensland Centre for Clinical Research
Apr 28, 2021

Parkinson Disease Trial in United States (Personal KinetiGraph® (PKG®) Watch, Personal KinetiGraph® (PKG®) Report)

Terminated
Has Results
  • Parkinson Disease
  • Personal KinetiGraph® (PKG®) Watch
  • Personal KinetiGraph® (PKG®) Report
  • Fayetteville, Arkansas
  • +16 more
Jan 12, 2022

Lewy Body Disease, Parkinson Disease Trial in Canada, United States (E2027)

Completed
  • Lewy Body Disease
  • Parkinson Disease
  • Sun City, Arizona
  • +13 more
Feb 4, 2022

Progressive Supranuclear Palsy Trial in United States (TPN-101, 100 mg/day, TPN-101, 200 mg/day, TPN-101, 400 mg/day)

Recruiting
  • Progressive Supranuclear Palsy
  • TPN-101, 100 mg/day
  • +3 more
  • La Jolla, California
  • +9 more
Mar 10, 2022

Amyotrophic Lateral Sclerosis Trial in Yangsan, Seoul (Lenzumestrocel, Riluzole, Placebo Comparator)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Lenzumestrocel
  • +2 more
  • Yangsan, Kyungsangnam-do, Korea, Republic of
  • +4 more
Mar 8, 2022

Alzheimer Trial in Australia, United States (ATH-1017)

Enrolling by invitation
  • Alzheimer Disease
  • Sun City, Arizona
  • +35 more
Feb 28, 2022

Alzheimer's Disease Trial in Las Vegas, Cleveland, Lakewood (Rasagiline, Placebo)

Completed
Has Results
  • Alzheimer's Disease
  • Las Vegas, Nevada
  • +2 more
Oct 21, 2020

PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

Recruiting
  • Parkinson Disease
    • Birmingham, Alabama
    • +50 more
    Jul 26, 2022

    ALS (Amyotrophic Lateral Sclerosis) Trial in Boston, Houston (Monthly autologous Treg cells infusions + 3 times per week

    Active, not recruiting
    • ALS (Amyotrophic Lateral Sclerosis)
    • Monthly autologous Treg cells infusions + 3 times per week Interleukin-2 injections
    • Monthly placebo infusions + 3 times per week placebo injections
    • Boston, Massachusetts
    • +1 more
    Sep 29, 2021

    Alzheimer Trial in United States (troriluzole, Placebo oral capsule)

    Completed
    • Alzheimer Disease
    • Phoenix, Arizona
    • +43 more
    Feb 15, 2022

    Alzheimer's Disease Trial in Las Vegas (Flortaucipir F18, Brain PET scan)

    Completed
    Has Results
    • Alzheimer's Disease
    • Flortaucipir F18
    • Brain PET scan
    • Las Vegas, Nevada
      Cleveland Clinic Lou Ruvo Center for Brain Health
    Aug 21, 2020

    Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol

    Recruiting
    • Mild Cognitive Impairment (MCI)
    • Alzheimer's Disease (AD)
      • Birmingham, Alabama
      • +58 more
      Jun 15, 2022

      Preclinical Alzheimer's Disease, Early Preclinical Alzheimer's Disease Trial in Worldwide (Lecanemab, Placebo)

      Recruiting
      • Preclinical Alzheimer's Disease
      • Early Preclinical Alzheimer's Disease
      • Birmingham, Alabama
      • +103 more
      Jun 14, 2022

      Schizophrenia, Schizoaffective Trial in New Haven (Riluzole, Placebo)

      Completed
      • Schizophrenia
      • Schizoaffective
      • New Haven, Connecticut
        Yale Department of Psychiatry
      Dec 6, 2019

      Amyotrophic Lateral Sclerosis Trial in Ann Arbor (Custom Mask Interface)

      Terminated
      • Amyotrophic Lateral Sclerosis
      • Custom Mask Interface
      • Ann Arbor, Michigan
        Michigan Medicine
      Apr 5, 2021

      Dementia Trial in Canada, United States (Escitalopram, Placebo)

      Recruiting
      • Dementia
      • Sun City, Arizona
      • +27 more
      May 6, 2021

      Alzheimer's Disease Neuroimaging Initiative 2

      Completed
      • Mild Cognitive Impairment (MCI)
      • +4 more
      • Birmingham, Alabama
      • +57 more
      Feb 11, 2022

      The Ontario Neurodegenerative Disease Research Initiative

      Completed
      • Alzheimer Disease
      • +4 more
      • Observational Cohort
      • Hamilton, Ontario, Canada
      • +11 more
      Sep 23, 2019

      Alzheimer's Disease Trial in Worldwide (BIIB092, Placebo)

      Terminated
      Has Results
      • Alzheimer's Disease
      • Birmingham, Alabama
      • +100 more
      Oct 18, 2022

      Alzheimer's Disease, Traumatic Brain Injury, Depression Trial in United States (Flortaucipir F18, Brain PET scan)

      Completed
      Has Results
      • Alzheimer's Disease
      • +2 more
      • Flortaucipir F18
      • Brain PET scan
      • Phoenix, Arizona
      • +4 more
      Aug 21, 2020